EUVIMEDEUVIMED entdecken
Crossref

Engineered Protein Nanoparticles Enable Targeted Topical Delivery of Upadacitinib for Enhanced Arthritis Therapy

Wenrui Zhang iD, Chaonan Jin, Chao Ma, Yiwen Wang, Xiaojian Ji, Yufei Guo, Jiali Yu, Chao Xue, Jiaxin Bai, Kai Liu iD, Jianyou Chen, Jian Zhu

ACS Applied Bio Materials · 06.04.2026 · 9 (7) · 3604-3612

DOI: 10.1021/acsabm.6c00048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 23.03.2026. Verfasst von Wenrui Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China. Hauptthemen laut MEDLINE: Nanoparticles, Heterocyclic Compounds, 3-Ring, Biocompatible Materials, Arthritis, Rheumatoid. Die Arbeit nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) is a chronic autoimmune disorder driven by persistent synovial inflammation and leading to joint destruction. Although the Janus kinase (JAK) inhibitor upadacitinib (UPA) is clinically effective, its systemic administration is associated with dose-limiting toxicities and poor patient adherence, highlighting an urgent need to minimize systemic exposure. Topical application offers a promising route for targeted joint delivery, but its efficacy is hampered by the formidable skin barrier and the poor retention of conventional formulations. To overcome these challenges, we developed a protein-based nanoparticle system by assembling engineered protein K72 with carboxylate-terminated poly(ethylene glycol) (PEG-COOH) to encapsulate UPA. This design significantly enhanced nanoparticle stability, drug loading capacity, and transdermal penetration efficiency. The engineered nanoparticles demonstrated sustained drug release and superior skin penetration. In a collagen-induced arthritis (CIA) mouse model, topical application of these nanoparticles achieved pronounced therapeutic efficacy against RA progression, with no observable systemic toxicity. This work establishes a safe, convenient, and highly effective topical nanoplatform for the local management of RA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesHeterocyclic Compounds, 3-RingBiocompatible MaterialsArthritis, RheumatoidArthritis, ExperimentalDrug Delivery SystemsAnimalsMiceAdministration, TopicalParticle SizeMaterials TestingDrug CarriersHumansPolyethylene Glycols

Stichwörter der Autor:innen

protein nanoparticlesrheumatoid arthritissustained releasetopical therapyupadacitinib

Substanzen

upadacitinibHeterocyclic Compounds, 3-RingBiocompatible MaterialsDrug CarriersPolyethylene Glycols

Autor:innen und Institutionen

  • Department of Rheumatology and Immunology, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.
  • Medical School of Chinese PLA, Beijing 100853, China.
  • Engineering Research Center of Advanced Rare Earth Materials (Ministry of Education), Department of Chemistry, Tsinghua University, Beijing 100084, China.
  • Second Department of Dermatology, Capital Center for Children's Health, Capital Medical University, Capital Institute of Pediatrics, Beijing 100020, China.

ORCID-Profile: Wenrui Zhang, Kai Liu

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Zhang, W., Jin, C., Ma, C., Wang, Y., Ji, X., Guo, Y., Yu, J., Xue, C., Bai, J., Liu, K., Chen, J., & Zhu, J. (2026). Engineered Protein Nanoparticles Enable Targeted Topical Delivery of Upadacitinib for Enhanced Arthritis Therapy. ACS Applied Bio Materials, 9(7), 3604-3612. https://doi.org/10.1021/acsabm.6c00048

Vancouver

Zhang W, Jin C, Ma C, Wang Y, Ji X, Guo Y, et al. Engineered Protein Nanoparticles Enable Targeted Topical Delivery of Upadacitinib for Enhanced Arthritis Therapy. ACS Applied Bio Materials. 2026;9(7):3604-3612. doi:10.1021/acsabm.6c00048

BibTeX
@article{Zhang2026,
  author = {Zhang, Wenrui and Jin, Chaonan and Ma, Chao and Wang, Yiwen and Ji, Xiaojian and Guo, Yufei and Yu, Jiali and Xue, Chao and Bai, Jiaxin and Liu, Kai and Chen, Jianyou and Zhu, Jian},
  title = {Engineered Protein Nanoparticles Enable Targeted Topical Delivery of Upadacitinib for Enhanced Arthritis Therapy},
  journal = {ACS Applied Bio Materials},
  year = {2026},
  volume = {9},
  number = {7},
  pages = {3604--3612},
  doi = {10.1021/acsabm.6c00048}
}
Kostenlos starten →